Cargando…
Pharmacology of L-type Calcium Channels: Novel Drugs for Old Targets?
Inhibition of voltage-gated L-type calcium channels by organic calcium channel blockers is a well-established pharmacodynamic concept for the treatment of hypertension and cardiac ischemia. Since decades these antihypertensives (such as the dihydropyridines amlodipine, felodipine or nifedipine) belo...
Autores principales: | Striessnig, Jörg, Ortner, Nadine J., Pinggera, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384371/ https://www.ncbi.nlm.nih.gov/pubmed/25966690 http://dx.doi.org/10.2174/1874467208666150507105845 |
Ejemplares similares
-
L-type calcium channels as drug targets in CNS disorders
por: Ortner, Nadine J, et al.
Publicado: (2015) -
Ca(v)1.3 (CACNA1D) L‐type Ca(2+) channel dysfunction in CNS disorders
por: Pinggera, Alexandra, et al.
Publicado: (2016) -
L-type Ca(2+) channels in heart and brain
por: Striessnig, Jörg, et al.
Publicado: (2014) -
C-Terminal Modulatory Domain Controls Coupling of Voltage-Sensing to Pore Opening in Ca(v)1.3 L-type Ca(2+) Channels
por: Lieb, Andreas, et al.
Publicado: (2014) -
Splice variants of the Ca(V)1.3 L-type calcium channel regulate dendritic spine morphology
por: Stanika, Ruslan, et al.
Publicado: (2016)